新技術が先進的医薬品の送達を可能に(New technology facilitates delivery of advanced medicines)

ad

2025-04-30 カロリンスカ研究所(KI)

ChatGPT:
カロリンスカ研究所の研究チームは、治療用タンパク質やRNAを細胞内に効率的に届ける新技術を開発した。この技術は、細胞外小胞(EV)に細菌由来のインテインとウイルス由来の融合タンパク質を導入することで、エンドソーム膜と融合し内部の治療物質を放出できるようにしたもの。従来のEVの課題である細胞内送達効率と放出効率の低さを克服した。マウス実験では、CreリコンビナーゼやCRISPR-Cas9を搭載したEVが脳内や全身炎症モデルで効果を示し、神経変性や遺伝性疾患などへの応用が期待される。

<関連情報>

ゲノムエディターを含むマルチモーダル治療薬の効率的細胞内デリバリーのための細胞外小胞のエンジニアリング Engineering of extracellular vesicles for efficient intracellular delivery of multimodal therapeutics including genome editors

Xiuming Liang,Dhanu Gupta,Junhua Xie,Elien Van Wonterghem,Lien Van Hoecke,Justin Hean,Zheyu Niu,Marziyeh Ghaeidamini,Oscar P. B. Wiklander,Wenyi Zheng,Rim Jawad Wiklander,Rui He,Doste R. Mamand,Jeremy Bost,Guannan Zhou,Houze Zhou,Samantha Roudi,H. Yesid Estupiñán,Julia Rädler,Antje M. Zickler,André Görgens,Vicky W. Q. Hou,Radka Slovak,Daniel W. Hagey,… Samir EL Andaloussi
Nature Communications  Published:29 April 2025
DOI:https://doi.org/10.1038/s41467-025-59377-y

新技術が先進的医薬品の送達を可能に(New technology facilitates delivery of advanced medicines)

Abstract

Intracellular delivery of protein and RNA therapeutics represents a major challenge. Here, we develop highly potent engineered extracellular vesicles (EVs) by incorporating bio-inspired attributes required for effective delivery. These comprise an engineered mini-intein protein with self-cleavage activity for active cargo loading and release, and fusogenic VSV-G protein for endosomal escape. Combining these components allows high efficiency recombination and genome editing in vitro following EV-mediated delivery of Cre recombinase and Cas9/sgRNA RNP cargoes, respectively. In vivo, infusion of a single dose Cre loaded EVs into the lateral ventricle in brain of Cre-LoxP R26-LSL-tdTomato reporter mice results in greater than 40% and 30% recombined cells in hippocampus and cortex respectively. In addition, we demonstrate therapeutic potential of this platform by showing inhibition of LPS-induced systemic inflammation via delivery of a super-repressor of NF-ĸB activity. Our data establish these engineered EVs as a platform for effective delivery of multimodal therapeutic cargoes, including for efficient genome editing.

生物工学一般
ad
ad
Follow
ad
タイトルとURLをコピーしました